Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C

Community-acquired pneumonia (CAP) is characterized by elevated markers of inflammation and oxidative stress and depleted circulating concentrations of the antioxidant nutrient vitamin C. A feasibility trial of intravenous and oral vitamin C supplementation, matched to the timing of intravenous and...

Full description

Bibliographic Details
Main Authors: Anitra C. Carr, Emma Vlasiuk, Masuma Zawari, Amy Scott-Thomas, Malina Storer, Michael Maze, Stephen T. Chambers
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/12/8/1610
_version_ 1827730563977445376
author Anitra C. Carr
Emma Vlasiuk
Masuma Zawari
Amy Scott-Thomas
Malina Storer
Michael Maze
Stephen T. Chambers
author_facet Anitra C. Carr
Emma Vlasiuk
Masuma Zawari
Amy Scott-Thomas
Malina Storer
Michael Maze
Stephen T. Chambers
author_sort Anitra C. Carr
collection DOAJ
description Community-acquired pneumonia (CAP) is characterized by elevated markers of inflammation and oxidative stress and depleted circulating concentrations of the antioxidant nutrient vitamin C. A feasibility trial of intravenous and oral vitamin C supplementation, matched to the timing of intravenous and oral antibiotic formulations, was carried out and changes in vitamin C status were monitored to determine whether saturating status could be achieved throughout the administration period. Patients with moderate and severe CAP (CURB-65 ≥ 2; <i>n</i> = 75) who were receiving intravenous antimicrobial therapy were randomized to placebo (<i>n</i> = 39) or intravenous vitamin C (2.5 g per 8 h; <i>n</i> = 36) before moving to oral vitamin C (1 g three times daily) when prescribed oral antimicrobials. Blood samples were collected at baseline and then daily whilst in the hospital. Vitamin C concentrations were determined by high-performance liquid chromatography. The inflammatory and infection biomarkers C-reactive protein and procalcitonin were elevated at baseline (158 (61, 277) mg/L and 414 (155, 1708) ng/L, respectively), and vitamin C concentrations were depleted (15 (7, 25) µmol/L). There was an inverse association between vitamin C and C-reactive protein concentrations (<i>r</i> = −0.312, <i>p</i> = 0.01). Within one day of intervention initiation, plasma vitamin C concentrations in the vitamin C group reached median concentrations of 227 (109, 422) µmol/L, and circulating concentrations remained at ≥150 µmol/L for the duration of the intervention, whilst median vitamin C concentrations in the placebo group remained low (≤35 µmol/L). There was a trend toward decreased duration of hospital stay (<i>p</i> = 0.07) and time to clinical stability (<i>p</i> = 0.08) in the vitamin C group. In conclusion, patients with moderate to severe CAP have inadequate plasma vitamin C concentrations for the duration of their hospital stay. The administration of intravenous or oral vitamin C, titrated to match the antimicrobial formulation, provided saturating plasma vitamin C concentrations whilst in the hospital. There were trends toward shorter duration of hospital stay and time to clinical stability. Thus, larger trials assessing the impact of intravenous and oral vitamin C intervention on CAP clinical outcomes are indicated.
first_indexed 2024-03-11T00:10:35Z
format Article
id doaj.art-6eea7e79a85047dabafca0560ff456d0
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-11T00:10:35Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-6eea7e79a85047dabafca0560ff456d02023-11-19T00:02:41ZengMDPI AGAntioxidants2076-39212023-08-01128161010.3390/antiox12081610Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin CAnitra C. Carr0Emma Vlasiuk1Masuma Zawari2Amy Scott-Thomas3Malina Storer4Michael Maze5Stephen T. Chambers6Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New ZealandDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New ZealandDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New ZealandDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New ZealandRespiratory Services, Christchurch Hospital, Christchurch 4710, New ZealandRespiratory Services, Christchurch Hospital, Christchurch 4710, New ZealandDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New ZealandCommunity-acquired pneumonia (CAP) is characterized by elevated markers of inflammation and oxidative stress and depleted circulating concentrations of the antioxidant nutrient vitamin C. A feasibility trial of intravenous and oral vitamin C supplementation, matched to the timing of intravenous and oral antibiotic formulations, was carried out and changes in vitamin C status were monitored to determine whether saturating status could be achieved throughout the administration period. Patients with moderate and severe CAP (CURB-65 ≥ 2; <i>n</i> = 75) who were receiving intravenous antimicrobial therapy were randomized to placebo (<i>n</i> = 39) or intravenous vitamin C (2.5 g per 8 h; <i>n</i> = 36) before moving to oral vitamin C (1 g three times daily) when prescribed oral antimicrobials. Blood samples were collected at baseline and then daily whilst in the hospital. Vitamin C concentrations were determined by high-performance liquid chromatography. The inflammatory and infection biomarkers C-reactive protein and procalcitonin were elevated at baseline (158 (61, 277) mg/L and 414 (155, 1708) ng/L, respectively), and vitamin C concentrations were depleted (15 (7, 25) µmol/L). There was an inverse association between vitamin C and C-reactive protein concentrations (<i>r</i> = −0.312, <i>p</i> = 0.01). Within one day of intervention initiation, plasma vitamin C concentrations in the vitamin C group reached median concentrations of 227 (109, 422) µmol/L, and circulating concentrations remained at ≥150 µmol/L for the duration of the intervention, whilst median vitamin C concentrations in the placebo group remained low (≤35 µmol/L). There was a trend toward decreased duration of hospital stay (<i>p</i> = 0.07) and time to clinical stability (<i>p</i> = 0.08) in the vitamin C group. In conclusion, patients with moderate to severe CAP have inadequate plasma vitamin C concentrations for the duration of their hospital stay. The administration of intravenous or oral vitamin C, titrated to match the antimicrobial formulation, provided saturating plasma vitamin C concentrations whilst in the hospital. There were trends toward shorter duration of hospital stay and time to clinical stability. Thus, larger trials assessing the impact of intravenous and oral vitamin C intervention on CAP clinical outcomes are indicated.https://www.mdpi.com/2076-3921/12/8/1610vitamin Cascorbic acidantioxidantintravenous vitamin Cpneumoniacommunity-acquired pneumonia
spellingShingle Anitra C. Carr
Emma Vlasiuk
Masuma Zawari
Amy Scott-Thomas
Malina Storer
Michael Maze
Stephen T. Chambers
Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
Antioxidants
vitamin C
ascorbic acid
antioxidant
intravenous vitamin C
pneumonia
community-acquired pneumonia
title Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
title_full Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
title_fullStr Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
title_full_unstemmed Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
title_short Low Vitamin C Concentrations in Patients with Community-Acquired Pneumonia Resolved with Pragmatic Administration of Intravenous and Oral Vitamin C
title_sort low vitamin c concentrations in patients with community acquired pneumonia resolved with pragmatic administration of intravenous and oral vitamin c
topic vitamin C
ascorbic acid
antioxidant
intravenous vitamin C
pneumonia
community-acquired pneumonia
url https://www.mdpi.com/2076-3921/12/8/1610
work_keys_str_mv AT anitraccarr lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc
AT emmavlasiuk lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc
AT masumazawari lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc
AT amyscottthomas lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc
AT malinastorer lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc
AT michaelmaze lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc
AT stephentchambers lowvitamincconcentrationsinpatientswithcommunityacquiredpneumoniaresolvedwithpragmaticadministrationofintravenousandoralvitaminc